Vivani treats first patient with long-lasting drug implant for weight loss
A day after announcing a business split-off to focus on weight loss and diabetes implants, Vivani Medical has implanted the…
Metabolic Disorders
-
-
Proteomics announces Australian launch of predictive diabetic kidney test
Proteomics International Laboratories has launched the PromarkerD diabetic kidney disease (DKD) predictive test in Australia. The test is said to…
-
FDA clears Tandem’s Control-IQ+ technology for type 2 diabetes
The US Food and Drug Administration (FDA) has cleared Tandem Diabetes Care’s Control-IQ+ technology, an automated insulin delivery algorithm, for use…
-
Allurion’s weight loss balloon back on French market
Seven months after suspending sales of its weight loss balloon in France due to safety concerns, Allurion’s products are back…
-
Allurion shares soar 77% after sharing plans for GLP-1RA combo trial
If you can’t beat them then join them. In a bid to combat weakening financial performance, Allurion has revealed plans…
-
Sequana shares surge after FDA approval for alfapump
The US Food and Drug Administration (FDA) has approved Sequana Medical’s alfapump for the treatment of recurrent or refractory ascites…
-
Vivani begins exenatide implant trial for obesity in Australia
Vivani Medical has commenced the first-in-human, randomised trial, LIBERATE-1, by initiating screening and enrolment to assess the pharmacokinetic and safety…
-
ClearNote and Southampton researchers partner for pancreatic cancer test study
ClearNote Health has announced a partnership with the University of Southampton's Clinical Trials Unit researchers to use the Avantect pancreatic…
-
“No magic wand” for Novo Nordisk, as CagriSema pen supply rumours swirl
Against a backdrop of manufacturing prioritisation, Novo Nordisk’s contract with Swiss medical technology Ypsomed could include the supply of injection…
-
Medtronic’s insulin pen app gains FDA clearance
Medtronic has received clearance from the US Food and Drug Administration (FDA) for its new InPen app, paving the way…
